Biocon Jumps 3% as Insulin Facility in Malaysia gets GMP Nod

Posted By: Religare
Subscribe to GoodReturns

    Shares of Biocon soared over 3 per cent on the Bombay Stock Exchange after the company said that its insulin facility in Malaysia received compliance certificate.

    Biocon Jumps 3% as Insulin Facility in Malaysia gets GMP Nod
    Biocon: Quotes, News
    BSE 659.55BSE Quote14.8 (2.24%)
    NSE 659.95NSE Quote14.6 (2.21%)

    Biocon said its subsidiary in Malaysia, Biocon Sdn. Bhd., received a certificate of 'GMP (Good Manufacturing Practice) Compliance' for its Insulins manufacturing facility by the HPRA (Ireland) as the representative European inspection authority.

    Following the statement, shares of the company gained as much as 3.18 per cent to trade at Rs 345.80 apiece on the Bombay Stock Exchange.

    In a similar fashion, shares of the company were trading 3.24 per cent higher at Rs 345.60 apiece on the National Stock Exchange.

    Meanwhile, the broader benchmark BSE Sensex was trading at 31,711.70, up 48.96 points, or 0.15 per cent, at 11:55 hours.

    Read more about: biocon
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more